Member Exclusive Journal content

Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics

This research article evaluates the persistence, adherence and healthcare costs among biologic-naive patients receiving apremilast or biologics for the treatment of psoriasis.

Please sign in or register for FREE

No comments yet.